This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of compounds targeting central nervous system disorders, such as depression, anxiety, and other neurological conditions. Its trifluoromethoxy group enhances the molecule's ability to interact with biological targets, improving its efficacy and stability. Additionally, it is explored in the development of receptor agonists or antagonists due to its structural properties, which allow for precise modulation of biological pathways. Its application is also seen in preclinical studies to evaluate pharmacokinetics and pharmacodynamics.